Fujian Cosunter Pharmaceutical Co Ltd (300436) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.055x

Based on the latest financial reports, Fujian Cosunter Pharmaceutical Co Ltd (300436) has a cash flow conversion efficiency ratio of -0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-25.74 Million ≈ $-3.77 Million USD) by net assets (CN¥468.48 Million ≈ $68.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Fujian Cosunter Pharmaceutical Co Ltd (300436) market capitalisation for the company's overall valuation and market capitalisation.

Fujian Cosunter Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Fujian Cosunter Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Fujian Cosunter Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fujian Cosunter Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Fujian Cosunter Pharmaceutical Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Meshek Energy-Renewable Energies Ltd TA:MSKE	0.010x
Liberty Media Corporation Series A Liberty Formula One Common Stock NASDAQ:FWONA	0.080x
Sunrun Inc NASDAQ:RUN	-0.034x
Business intelligence of Oriental Nations Corp Ltd SHE:300166	0.000x
Electricity Generating Public Company Limited BK:EGCO	0.000x
Banco do Nordeste do Brasil S.A SA:BNBR3	-0.200x
Bitdeer Technologies Group Class A Ordinary Shares NASDAQ:BTDR	-0.475x
Levi Strauss & Co Class A NYSE:LEVI	0.119x

Annual Cash Flow Conversion Efficiency for Fujian Cosunter Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Fujian Cosunter Pharmaceutical Co Ltd from 2011 to 2025. View 300436 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥346.30 Million ≈ $50.67 Million	CN¥-35.05 Million ≈ $-5.13 Million	-0.101x	-293.94%
2024-12-31	CN¥396.78 Million ≈ $58.06 Million	CN¥20.71 Million ≈ $3.03 Million	0.052x	+117.02%
2023-12-31	CN¥569.24 Million ≈ $83.30 Million	CN¥-174.60 Million ≈ $-25.55 Million	-0.307x	-144.91%
2022-12-31	CN¥955.62 Million ≈ $139.84 Million	CN¥-119.68 Million ≈ $-17.51 Million	-0.125x	-640.11%
2021-12-31	CN¥1.05 Billion ≈ $153.63 Million	CN¥-17.76 Million ≈ $-2.60 Million	-0.017x	-163.14%
2020-12-31	CN¥581.99 Million ≈ $85.16 Million	CN¥15.60 Million ≈ $2.28 Million	0.027x	-54.76%
2019-12-31	CN¥573.74 Million ≈ $83.96 Million	CN¥33.99 Million ≈ $4.97 Million	0.059x	+204.40%
2018-12-31	CN¥562.35 Million ≈ $82.29 Million	CN¥10.94 Million ≈ $1.60 Million	0.019x	-84.97%
2017-12-31	CN¥552.05 Million ≈ $80.78 Million	CN¥71.47 Million ≈ $10.46 Million	0.129x	-3.16%
2016-12-31	CN¥552.36 Million ≈ $80.83 Million	CN¥73.84 Million ≈ $10.81 Million	0.134x	-37.82%
2015-12-31	CN¥519.20 Million ≈ $75.97 Million	CN¥111.63 Million ≈ $16.33 Million	0.215x	-68.49%
2014-12-31	CN¥156.87 Million ≈ $22.96 Million	CN¥107.04 Million ≈ $15.66 Million	0.682x	+47.49%
2013-12-31	CN¥143.10 Million ≈ $20.94 Million	CN¥66.20 Million ≈ $9.69 Million	0.463x	+19.69%
2012-12-31	CN¥108.59 Million ≈ $15.89 Million	CN¥41.97 Million ≈ $6.14 Million	0.387x	-52.42%
2011-12-31	CN¥65.43 Million ≈ $9.58 Million	CN¥53.15 Million ≈ $7.78 Million	0.812x	--

About Fujian Cosunter Pharmaceutical Co Ltd

SHE:300436 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.12 Billion

CN¥14.47 Billion CNY

Market Cap Rank

#6018 Global

#1143 in China

Share Price

CN¥90.87

Change (1 day)

+1.25%

52-Week Range

CN¥80.19 - CN¥135.35

All Time High

CN¥172.22